Ube Corporation · TSE:4208
Ube — Ube Industries — FY2016 Earnings Presentation
30 slides from Ube's earnings presentation, May 11, 2017
Slide 1: FY2016 Consolidated Results, FY2017 Consolidated Forecasts
1 FY2016 Consolidated Results FY2017 Consolidated Forecasts May 11, 2017
Slide 2: Contents
2 Contents ・ FY2016 Consolidated Results ・ FY2017 Consolidated Forecasts ・ Appendix
Slide 3: FY2016 Consolidated Results
3 FY2016 Consolidated Results
Slide 4: Scope of Consolidation
4 Scope of Consolidation - FY2016 Consolidated Results - End of FY2015 End of FY2016 Change Item Notes (A) (B) （B) - （A) Number of U-MHI Platech Co., Ltd. consolidated 68 70 2 subsidiaries U&M Plastic Solutions Co.,Ltd. Number of equity method 25 25 0 affiliates Total 93 95 2
Slide 5: Environmental Factors: Naphtha Material Price
5 Environmental Factors - FY2016 Consolidated Results - FY2015 FY2016 Change Item (A) (B) (B) - (A) Exchange Rate Yen/$ 120.1 108.4 -11.7 484 430 -54 Naphtha CIF $/ｔ 42,600 34,500 -8,100 Material Price Domestic Yen/KL Benzene(ACP) $/ｔ 667 723 56 Australian $/ｔ 73.6 80.7 7.1 Coal (CIF) Yen/t 8,843 8,
Slide 6: Major P/L & B/S Items
6 Major P/L ＆ B/S Items - FY2016 Consolidated Results - (Billion Yen) FY2015 FY2016 Change Item (A) (B) (B) - (A) Net sales 641.7 616.5 -25.1 Operating income 41.4 34.9 -6.4 Ordinary income 39.6 33.3 -6.2 Profit attributable to owners of parent 19.1 24.1 5.0 End of FY2015 End of FY2016 Change Item (
Slide 7: Sales by Segment
7 Sales by Segment - FY2016 Consolidated Results - （Billion Yen） FY2015 FY2016 Change Segment Major Factors (A) (B) (B) - (A) Nylon/Caprolactam chain -13.7, Synthetic rubber 2.9, Chemicals 266.7 258.3 -8.3 Battery Materials and Fine Chemicals 4.5, Polyimide and Specialty Products -0.1, etc Pharmaceu
Slide 8: Operating Income by Segment
8 Operating Income by Segment - FY2016 Consolidated Results - （Billion Yen） FY2015 FY2016 Change Segment Major Factors (A) (B) (B) - (A) Nylon/Caprolactam chain -3.0, Synthetic rubber -1.8, Chemicals 12.0 9.6 -2.4 Battery Materials and Fine Chemicals 0.2, Polyimide and Specialty Products 0.3, etc Ph
Slide 9: Analysis of Operating Income
9 Analysis of Operating Income - FY2016 Consolidated Results - （Billion Yen） Operating Income Segment Change FY2015 FY2016 Sales Fixed Price Others (A) (B) (B) - (A) *1 Volume Cost *2 Chemicals 12.0 9.6 -2.4 -2.4 1.9 -4.7 2.7 Pharmaceutical 1.1 2.4 1.3 -0.1 1.8 -0.2 -0.1 Cement & construction 19.8 1
Slide 10: Non Operating Items
10 Non Operating Items - FY2016 Consolidated Results - （Billion Yen） FY2015 FY2016 Change Item (A) (B) (B) - (A) Operating income 41.4 34.9 -6.4 Net interest expenses -1.1 -0.7 0.4 Share of profit of entities income/expenses 2.9 2.0 -0.9 Non-operating accounted for using equtiy method Foreign curren
Slide 11: Extraordinary Items
11 Extraordinary Items - FY2016 Consolidated Results - （Billion Yen） FY2015 FY2016 Change Item (A) (B) (B) - (A) Gain on bargain purchase - 1.6 1.6 Reversal of accured expenses from business withdrawal 1.5 - -1.5 Loss on disposal of non-current assets -5.3 -2.4 2.8 Impairment loss -9.0 -0.5 8.4 Othe
Slide 12: Operating Income - Net Income
12 Operating Income - Net Income - FY2016 Consolidated Results - （Billion Yen） FY2015 FY2016 Change Item (A) (B) (B) - (A) Operating income 41.4 34.9 -6.4 Non-operating income/expenses -1.7 -1.6 0.1 Ordinary income 39.6 33.3 -6.2 Extraordinary income/losses -11.9 -0.4 11.5 Profit befor income taxes
Slide 13: Consolidated Balance Sheet
13 Consolidated Balance Sheet - FY2016 Consolidated Results - （Billion Yen） FY2015 FY2016 Change Item (A) (B) (B) - (A) Current assets 276.9 295.0 18.1 Fixed assets 402.7 414.2 11.4 Total assets 679.7 709.3 29.5 Interest-bearing debts 216.6 210.4 -6.2 Other liabilities 173.4 188.5 15.0 Total liabili
Slide 14: Consolidated Statements of Cash Flows
14 Consolidated Statements of Cash Flows - FY2016 Consolidated Results - （Billion Yen） Item FY2015 FY2016 Profit before income taxes 32.9, A.Cash flows from operating activities 68.6 53.4 Depreciation and amortization 34.4, Payment of Tax and others -10.2, etc. B.Cash flows from investing activities
Slide 15: FY2017 Consolidated Forecasts
15 FY2017 Consolidated Forecasts
Slide 16: Scope of Consolidation
16 Scope of Consolidation - FY2017 Consolidated Forecasts - End of End of Change Item FY2016 FY2017 Notes (A) (B) （B) - （A) Number of － Fukusei Tech Co.,Ltd consolidated 70 70 0 + UBE (Shanghai) Ltd. subsidiaries Number of － UBE (Shanghai) Ltd. equity method 25 24 -1 － Samekawa Ready-mixed Concrete
Slide 17: Environmental Factors: Naphtha Material Price
17 Environmental Factors - FY2017 Consolidated Forecasts - FY2016 FY2017 Change Item (A) (B) (B) - (A) Exchange Rate Yen/$ 108.4 110.0 1.6 Naphtha CIF $/ｔ 430 520 90 Material Price Domestic Yen/KL 34,500 41,800 7,300 Benzene(ACP) $/ｔ 723 750 27 Australian $/ｔ 80.7 99.4 18.7 Coal (CIF) Yen/t 8,748 10
Slide 18: Major P/L & B/S Items
18 Major P/L ＆ B/S Items - FY2017 Consolidated Forecasts - （Billion Yen） FY2016 FY2017 Difference Item (A) (B) (B) - (A) Net sales 616.5 700.0 83.5 Operating income 34.9 40.0 5.1 Ordinary income 33.3 38.0 4.7 Profit attributable to owners of parent 24.1 24.5 0.4 End of FY2016 End of FY2017 Differenc
Slide 19: Sales by Segment
19 Sales by Segment - FY2017 Consolidated Forecasts - （Billion Yen） FY2016 FY2017 Difference Segment Major Factors (A) (B) (B) - (A) Nylon/Caprolactam chain 8.5, Synthetic rubber 19.0, Chemicals 258.3 310.0 51.7 Battery Materials and Fine Chemicals 8.9, Polyimide and Specialty Products 1.9, etc Phar
Slide 20: Operating Income by Segment
20 Operating Income by Segment - FY2017 Consolidated Forecasts - （Billion Yen） FY2016 FY2017 Difference Segment Major Factors (A) (B) (B) - (A) Nylon/Caprolactam chain 0.4, Synthetic rubber 4.0, Chemicals 9.6 18.0 8.4 Battery Materials and Fine Chemicals 3.9, Polyimide and Specialty Products 0.3, et
Slide 21: Analysis of Operating Income
21 Analysis of Operating Income - FY2017 Consolidated Forecasts - （Billion Yen） Operating Income Segment Change FY2016 FY2017 Sales Fixed Price Others (A) (B) (B) - (A) *1 Volume Cost *2 Chemicals 9.6 18.0 8.4 1.3 8.7 -0.5 -1.2 Pharmaceutical 2.4 2.0 -0.4 0.1 -0.7 -0.1 0.3 Cement & Construction 16.2
Slide 22: Operating Income - Net Income
22 Operating Income - Net Income - FY2017 Consolidated Forecasts - （Billion Yen） FY2016 FY2017 Difference Item (A) (B) (B) - (A) Operating income 34.9 40.0 5.1 Non-operating income/expenses -1.6 -2.0 -0.4 Ordinary income 33.3 38.0 4.7 Extraordinary income/losses -0.4 -3.0 -2.6 Profit before income t
Slide 23: Appendix
23 Appendix UBE
Slide 24: FY2016 Changes in Results - Sales by Segment
24 【Reference】 FY2016 Changes in Results - Sales by Segment - (Billion Yen) FY2016 Full-year Segment 1Q 2Q 3Q 4Q Total Forecast Chemicals 57.9 60.0 65.5 74.8 258.3 250.0 Pharmaceutical 2.4 2.0 2.5 3.8 10.9 10.0 Cement & 53.8 55.9 59.6 57.8 227.2 230.0 Construction Materials Machinery 12.6 13.9 16.5
Slide 25: FY2016 Changes in Results - Operating Income by Segment
25 【Reference】 FY2016 Changes in Results - Operating Income by Segment - (Billion Yen) FY2016 Full-year Segment 1Q 2Q 3Q 4Q Total Forecast Chemicals -2.3 2.8 4.0 5.2 9.6 8.5 Pharmaceutical 0.4 0.6 0.4 0.8 2.4 2.0 Cement & 2.9 4.4 5.0 3.7 16.2 16.0 Construction Materials Machinery -0.0 0.8 0.7 2.1 3.
Slide 26: FY2017 Forecasts - Sales / Operating Income in Half Years
26 【Reference】 FY2017 Consolidated Forecasts - Sales / Operating Incom in Half Years - （Billion Yen） Sales Operating income Segment First half Second half Total First half Second half Total Chemicals 150.0 160.0 310.0 8.0 10.0 18.0 Pharmaceutical 5.0 5.0 10.0 1.5 0.5 2.0 Cement & Construction Materi
Slide 27: Major data
27 【Reference】 Major data - FY2016 Consolidated Results - (Billion Yen) FY2017 Item FY2015 FY2016 Forecast Capital investment 34.4 44.0 42.0 Depreciation and amortization 35.5 34.4 35.0 R&D expenses 13.7 13.6 14.5 Adjusted operating income 45.2 37.8 43.5 Interest-bearing debt 216.6 210.4 200.0 Equit
Slide 28: Major Subsidiaries
28 【Reference】 Major Subsidiaries - FY2016 Consolidated Results - (Billion Yen) Operating Sales income Subsidiaries and Affiliates Business change from FY2015 FY2014 UBE CHEMICALS (ASIA) PUBLIC CO., LTD Manufacture and sales of caprolactam and polyamide resin 35.8 ↑ Manufacture and sales of caprolac
Slide 29: Major Items for Capital Expenditure
29 【Reference】 Major Items for Capital Expenditure - FY2017 Consolidated Forecasts - Estimeated Segment Subject Place completion date Changing to phenol method for Ube, Japan FY2017 cyclohexanone production Expanding production capacity of large- Ube, Japan FY2017 grain ammonium sulfate Chemicals Ex
Slide 30: Forward-looking statements notice
30 This presentation material contains forward-looking statements concerning UBE’s future plans, strategies, and performance. These forward-looking statements are not historical facts; rather, they represent assumptions and beliefs based on economic, financial, and competitive date currently availab